NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/26/2023
Back to search
Official data from USPTO
ACCELERATE BRAIN CANCER CURE, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCELERATE BRAIN CANCER CURE, INC.
ST13
US500000076286418Class
42
Filing
76286418
Registration
2593276
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/26/2023
Trademark type
Word
Nice classes
42
Filing date
07/10/2001
Registration date
07/09/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/26/2023
Last transaction
07/26/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2001-10-00
First use in commerce
2001-10-00
Drawing code
1
Owner type
03
Owner location
Washington, DC, US
Examiner
REGAN, JOHN B
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc.
Representatives
Michael R. Graif Mintz Levin Cohn Ferris Glovsky & Popeo, PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting brain cancer research and clinical trials; providing information on brain cancer research and clinical trials; promoting brain cancer awarenessresearch and clinical trials
Publications
History of USPTO decisions and trademark events.
24 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/26/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/26/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/26/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
01/06/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
03/27/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/27/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/27/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
03/11/2012
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/23/2008
PLGL
ASSIGNED TO PARALEGAL
11/14/2008
ES8R
TEAS SECTION 8 RECEIVED
11/10/2008
CFIT
CASE FILE IN TICRS
10/15/2007
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/09/2002
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/09/2002
IUAA
USE AMENDMENT ACCEPTED
04/09/2002
CNEA
EXAMINERS AMENDMENT MAILED
04/05/2002
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/26/2002
IUAF
USE AMENDMENT FILED
03/04/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2002
PAPER RECEIVED
03/04/2002
CNRT
NON-FINAL ACTION MAILED
09/04/2001
DOCK
ASSIGNED TO EXAMINER
08/29/2001
Continuous trademark protection
Get notified about every new filing that threatens ACCELERATE BRAIN CANCER CURE, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.